In October 2025, the FDA announced a Class I recall for over 100,000 Automated Impella Controller (AIC) devices manufactured by Johnson & Johnson MedTech due to a significant cybersecurity risk. The AIC serves as the primary user control interface for...
We've done the analysis so you can make the decisions
Search our repository of 8,019 high-quality, objective, peer-reviewed case studies, impacting 8,042 companies and resulting in $49,131,959,620 in net costs